Item 1.02. Termination of a Material Definitive Agreement On October 9, 2026, Adia Med, Inc. (the “Company”) fully repaid and discharged its unsecured revolving line of credit facility originally entered into on June 30, 2024, between Larry Powalisz, Chief Executive Officer of the Company, as lender (the “Lender”), and the Company (and its relevant subsidiaries, as applicable), as borrower.…
Filed Oct 13, 2026Accepted Oct 13, 2026, 7:46 AM EDTCIK 1160420Accession 0001683168-26-007770
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.02Item 1.02 - Termination of Material Agreement
Item 1.02. Termination of a Material Definitive Agreement
On October 9, 2026, Adia Med, Inc. (the “Company”) fully
repaid and discharged its unsecured revolving line of credit facility originally entered into on June 30, 2024, between Larry Powalisz,
Chief Executive Officer of the Company, as lender (the “Lender”), and the Company (and its relevant subsidiaries, as applicable),
as borrower.
The Facility had been increased over time to a commitment of $1,000,000
by the Lender, to best accommodate the growth needs of the Company, and bore interest at 6% per annum calculated daily.
In satisfaction of the obligation to the Lender, the Company made the
following payments to the Lender:
October 7, 2026: $500,000;
October 9, 2026: $434,970.94 (of which $74,658.94 constituted accrued interest,
and the balance applied to principal).
Total amount paid to the Lender was $934,970.94.
The Lender has acknowledged that the outstanding principal balance
and all accrued interest under the Facility have been paid in full as of October 9, 2026. As a result, the Facility is satisfied in full,
with respect to all amounts owing through that date.
The Lender, a related party, is the Chief Executive Officer of the
Company.
The foregoing facility is satisfied and discharged and qualified in
its entirety by reference to the full text of the Paid-in-Full Acknowledgment dated October 9, 2026, a copy of which is filed as Exhibit
10.1 to this Current Report on Form 8-K and is incorporated herein by reference.